Download presentation
Presentation is loading. Please wait.
1
GDF-15 levels in progressors and nonprogressors in albuminuria (case and control subjects) for patients with T2DM and nondiabetic patients with HT. A: GDF-15 levels (pg/mL) (mean ± SE) in progressors and nonprogressors in albuminuria for T2DM and HT. B: GDF-15 levels (pg/mL) (mean ± SE) in progressors and nonprogressors in albuminuria for T2DM and HT stratified for baseline albuminuria (normoalbuminuria [Normo] or microalbuminuria [Micro]); *P < 0.05, **P < GDF-15 levels in progressors and nonprogressors in albuminuria (case and control subjects) for patients with T2DM and nondiabetic patients with HT. A: GDF-15 levels (pg/mL) (mean ± SE) in progressors and nonprogressors in albuminuria for T2DM and HT. B: GDF-15 levels (pg/mL) (mean ± SE) in progressors and nonprogressors in albuminuria for T2DM and HT stratified for baseline albuminuria (normoalbuminuria [Normo] or microalbuminuria [Micro]); *P < 0.05, **P < Macro, macroalbuminuria. Merel E. Hellemons et al. Dia Care 2012;35: ©2012 by American Diabetes Association
![GDF-15 levels in progressors and nonprogressors in albuminuria (case and control subjects) for patients with T2DM and nondiabetic patients with HT. A: GDF-15 levels (pg/mL) (mean ± SE) in progressors and nonprogressors in albuminuria for T2DM and HT. B: GDF-15 levels (pg/mL) (mean ± SE) in progressors and nonprogressors in albuminuria for T2DM and HT stratified for baseline albuminuria (normoalbuminuria [Normo] or microalbuminuria [Micro]); *P < 0.05, **P <](http://slideplayer.com/slide/17492271/102/images/1/GDF-15+levels+in+progressors+and+nonprogressors+in+albuminuria+%28case+and+control+subjects%29+for+patients+with+T2DM+and+nondiabetic+patients+with+HT.+A%3A+GDF-15+levels+%28pg%2FmL%29+%28mean+%C2%B1+SE%29+in+progressors+and+nonprogressors+in+albuminuria+for+T2DM+and+HT.+B%3A+GDF-15+levels+%28pg%2FmL%29+%28mean+%C2%B1+SE%29+in+progressors+and+nonprogressors+in+albuminuria+for+T2DM+and+HT+stratified+for+baseline+albuminuria+%28normoalbuminuria+%5BNormo%5D+or+microalbuminuria+%5BMicro%5D%29%3B+%2AP+%3C+0.05%2C+%2A%2AP+%3C.jpg "GDF-15 levels in progressors and nonprogressors in albuminuria (case and control subjects) for patients with T2DM and nondiabetic patients with HT. A: GDF-15 levels (pg/mL) (mean ± SE) in progressors and nonprogressors in albuminuria for T2DM and HT. B: GDF-15 levels (pg/mL) (mean ± SE) in progressors and nonprogressors in albuminuria for T2DM and HT stratified for baseline albuminuria (normoalbuminuria [Normo] or microalbuminuria [Micro]); *P < 0.05, **P < Macro, macroalbuminuria. Merel E. Hellemons et al. Dia Care 2012;35: ©2012 by American Diabetes Association.")
Similar presentations
